A renaissance in peptide-based pharmaceuticals has occurred recently as new technologies have emerged to make peptides more viable as drug candidates. According to the Peptide Therapeutics Foundation (peptidetherapeutics.org) 54 therapeutic peptides have been approved worldwide, including 26 drugs in the US, and the number of peptides under clinical evaluation has doubled over the past decade.

JT Pharmaceuticals (JT Pharma) is a peptide drug development company. We are focused on creating new drugs for acute, medically underserved, conditions. Peptide-based therapeutics provides direct access to novel, safe and efficacious pharmaceutical products.

The Peptide Advantage The JT Pharma Advantage